AMRX — Amneal Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AMRX
| date | signal | measured base rate |
|---|---|---|
| 2026-08-14 | Cluster sale: three or more insiders insider | -0.36% over 21 days · t = -3.35 · n = 21,529 statistically distinguishable from its control group |
| 2026-08-03 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-07-31 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-29 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-07-17 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-26 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-13 | Kiely John Director | Open-market sale | 50.0K | 17.64 | 882.0K |
| 2026-08-13 | Kiely John Director | Gift | 10.0K | 0.00 | 0 |
| 2026-08-12 | Daly Jason B. EVP, Chief Legal Officer | Open-market sale | 210.0K | 17.40 | 3.7M |
| 2026-08-12 | Shah Nikita Executive Vice President | Open-market sale | 146.4K | 17.51 | 2.6M |
| 2026-08-11 | BUCHI J KEVIN Director | Option exercise | 168.6K | 17.18 | 2.9M |
| 2026-08-11 | Daly Jason B. EVP, Chief Legal Officer | Open-market sale | 6.6K | 17.70 | 117.1K |
| 2026-08-10 | Patel Chintu Co-CEO | Grant or award | 6.4M | — | — |
| 2026-08-10 | Patel Gautam Director | Grant or award | 283.6K | — | — |
| 2026-08-10 | Patel Chirag K. President & Co-CEO | Grant or award | 6.4M | — | — |
| 2026-08-10 | Patel Tushar Bhikhubhai 10% owner | Grant or award | 12.8M | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 304.8M | 24.5M |
| TPG GP A, LLC | 153.2M | 12.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 140.8M | 11.3M |
| Rubric Capital Management LP | 137.2M | 11.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 94.3M | 7.6M |
| STATE STREET CORP | 84.5M | 6.8M |
| DIMENSIONAL FUND ADVISORS LP | 70.7M | 5.7M |
| MORGAN STANLEY | 57.6M | 4.6M |
| GEODE CAPITAL MANAGEMENT, LLC | 56.5M | 4.5M |
| NEUBERGER BERMAN GROUP LLC | 45.7M | 3.7M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 4 | 2026-08-14 | 2026-08-13 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-12 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-11 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-11 | on EDGAR ↗ |
| 144 | 2026-08-13 | — | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| SCHEDULE 13D/A | 2026-08-12 | — | on EDGAR ↗ |
| SCHEDULE 13D/A | 2026-08-12 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
Ask the AI about AMRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →